详情页 - 聚合机构库演示平台

当前位置：首页 > 详情页

Circulating tumor DNA to predict response and resistance by anti-PD-1 therapy in Chinese relapsed/refractory classic Hodgkin lymphoma

文献详情

资源类型：

WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：

单位： [1]Mil Chinese Peoples Liberat Army, Hosp 307, Beijing, Peoples R China [2]Zhengzhou Univ, Affiliated Canc Hosp, Dept Hematol, Zhengzhou, Henan, Peoples R China [3]Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China [4]Dalian Med Univ, Hosp 2, Dept Oncol, Dalian, Peoples R China [5]Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China [6]Chinese Acad Med Sci, Inst Canc, Beijing, Peoples R China [7]Peking Union Med Coll, Beijing, Peoples R China [8]Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China [9]Soochow Univ, Affiliated Hosp 1, Dept Haematol, Suzhou, Jiangsu, Peoples R China [10]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Wuhan, Hubei, Peoples R China [11]Guangzhou Med Univ, Canc Hosp, Guangzhou, Guangdong, Peoples R China [12]Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China [13]Chinese Acad Med Sci, Blood Inst, Tianjin, Peoples R China [14]Jilin Univ, Hosp 1, Ctr Canc, Jilin, Jilin, Peoples R China [15]ChangHai Hosp, Shanghai, Peoples R China [16]Shandong Univ, Qilu Hosp, Jinan, Shandong, Peoples R China [17]Innovent Biotech, Suzhou, Peoples R China [18]Innovent Biol Suzhou Co Ltd, Suzhou, Peoples R China [19]Geneplus Beijing Inst, Beijing, Peoples R China [20]Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Beijing, Peoples R China [21]Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Beijing, Peoples R China

出处：

ISSN：

语种：

WOS：

中科院(CAS)分区：

出版当年[2018]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2017]版：

Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY

影响因子： 42.1 最新[2023版] 37.4 最新五年平均 26.36 出版当年[2017版] 21.472 出版当年五年平均 24.008 出版前一年[2016版] 28.349 出版后一年[2018版]

第一作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：